Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform,...
Iambic and Takeda have announced a multi-year technology and discovery collaboration agreement to advance the AI-driven design and development of high-priority small molecule drug...
TetraScience , the scientific data and AI company, launched its Scientific AI Lighthouse (SAIL) program with Takeda as a founding partner. This program introduces...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration...